Study Title and Description
Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Safety and efficacy of the early introduction of everolimus with reduced-exposure cyclosporine a in de novo kidney recipients.|
|Author||Oh CK., Huh KH., Ha J., Kim YH., Kim YL., Kim YS.|
|Country||1 Department of Surgery, Ajou University School of Medicine, Suwon, Korea. 2 Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. 3 Department of Surgery, Seoul National University College of Medicine, Seoul, Korea. 4 Department of Nephrology, Inje University School of Medicine, Busan, Korea. 5 Department of Nephrology, Kyungpook National University School of Medicine, Daegu, Korea.|
Pubmed ID: 24983307
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.